1Kawakami Y, Akahane T, Yamaguchi M, et al. ln vitro activities of rabeprazole, a novel proton pump inhibitor and its thioether derivative alone and combination with other antimicrobials against recent clinical isolates of Helieobacter pylori[J]. Antimicrob Agent Chemother, 2000, 44: 458.
2McColl K, Kennerley P. Proton pump inhibitors-differences emerge in hepatic metabolism[J]. Dig Liver Dis, 2002, 34:461 -467.
4Langty HD, Markham A. Rabeprazole: a review of its use in acid - related gastrointestinal disorders[J]. Drugs, 1999, 58:725 - 742.
5Carswell CI, Goa KL. Rabeprazole: an update of its use in acid - related disorders[J]. Drugs, 2001, 61:2 327.
6Tytgat GNJ. Short comings of the first - generation proton pump inhibitors [J]. Eur J Gastroenterol Hapatol, 2001, 131 s29.
7Mehta DR, Maseeh A. Prevention of acid aspiration during surgery for cancer using I. V rabeprazole[J]. J Clin Oncol, 2005, 23:8 275.
8Park JB, Imamura L, Kobashi K. Kinetic studies of Helicobacter pylofi urease inhibition by a novel proton pump inhibitor, rabeprazole[J]. Biol Pharm Bull, 1996, 19:182 - 187.
9Tsuchiya M, Imamura L, Park JB, et al. Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor[J]. Biol Pharm Bull, 1995, 18:1 053 - 1 056.
10Li XQ, Andersson TB, Weidolf L, et al. Comparison of inhibitory effects of the proton pump- inhibiting drugs Omeprazole, Lansoprazole, Pantoprazole, Esomeprazole and Rabeprazole on human cytochrome P450 activities[J]. Drug Metab Dispos, 2004, 32:821 - 827.
